EE232 Impact of Updated Mortality Estimates on the Cost-Effectiveness of Rifaximin for the Treatment of Patients with Overt Hepatic Encephalopathy

Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.533
https://www.valueinhealthjournal.com/article/S1098-3015(23)00633-2/fulltext
Title : EE232 Impact of Updated Mortality Estimates on the Cost-Effectiveness of Rifaximin for the Treatment of Patients with Overt Hepatic Encephalopathy
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00633-2&doi=10.1016/j.jval.2023.03.533
First page :
Section Title :
Open access? : No
Section Order : 10019
Categories :
Tags :
Regions :
ViH Article Tags :